Work

A phase I study of once-weekly aminoflavone prodrug (AFP464) in solid tumor patients.

Year: 2011

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2011.29.15_suppl.2546

Authors: M. P. Goetz, J. M. Reid, Y. Qi, A. Chen, R. M. McGovern, M. J. Kuffel, P. D. Scanlon, C. Erlichman, M. M. Ames

Language: English

Topic: Bioactive Compounds and Antitumor Agents

Subfield: Toxicology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2590103753

Cites:

Cited by: 16

Related to: 10